Striatal trophic activity is reduced in the aged rat brain

Brain Research

Volumn 856, Issue 1-2, 2000, Pages 301-309

  Ling, Zao Dung ^a   Collier, Timothy J ^a   Sortwell, Caryl E ^a   Lipton, Jack W ^a   Vu, Toan Q ^a   Robie, Heather C ^a   Carvey, Paul M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

6 OHDA; Aging; Dopamine; Rat; Transplantation; Trophic

Indexed keywords

DOPAMINE; HOMOVANILLIC ACID; OXIDOPAMINE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN TRANSPLANTATION; CELL COUNT; CORPUS STRIATUM; GRAFT SURVIVAL; MESENCEPHALON; NERVE DEGENERATION; NERVE FUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT;

AGING; ANIMALS; BRAIN; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DOPAMINE; EMBRYO; FUNCTIONAL LATERALITY; HOMOVANILLIC ACID; MESENCEPHALON; NEURONS; OXIDOPAMINE; RATS; RATS, INBRED F344; TISSUE EXTRACTS;

EID: 0033955365     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)01945-4     Document Type: Article

References (66)

1. P. Brundin, R.E. Strecker, O. Lindvall, O. Isacson, O.G. Nilsson, G. Barbin, A. Prochiantz, C. Forni, A. Nieoullon, H. Wiener, Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease, Ann. N.Y. Acad. Sci. 495 (1987) 473-496.
2. D.M. Yurek, J.R. Sladek Jr., Dopamine cell replacement: Parkinson's disease, Annu. Rev. Neurosci. 13 (1990) 415-440.
3. C.W. Olanow, J.H. Kordower, T.B. Freeman, Fetal nigral transplantation as a therapy for Parkinson's disease, Trends Neurosci. 19 (1996) 102-109.
4. J.H. Kordower, J.M. Rosenstein, T.J. Collier, M.A. Burke, E.Y. Chen, J.M. Li, L. Martel, A.E. Levey, E.J. Mufson, T.B. Freeman, C.W. Olanow, Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies, J. Comp. Neurol. 370 (1996) 203-230.
5. P. Piccini, D.J. Brooks, A. Biorklund, R.N. Gunn, P.M. Grasby, O. Rimoldi, P. Brundin, P. Hagell, S. Rehncrona, H. Widner, O. Lindvall, Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient, Nature Neurosci. 2 (1999) 1137-1140.
6. T.J. Collier, C.E. Sortwell, B.F. Daley, Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: an argument for neurotrophic supplementation, J. Neurosci. 19 (1999) 5563-5573.
7. F.H. Gage, A. Bjorklund, U. Stenevi, S.B. Dunnett, Intracerebral grafting of neuronal cell suspensions. VIII. Survival and growth of implants of nigral and septal cell suspensions in intact brains of aged rats, Acta Physiol. Scand. Suppl. 522 (1983) 67-75.
8. C.R. Freed, R.E. Breeze, P.E. Greere, W.-Y. Tsai, D. Eidelberg, J.Q. Trojanowski, J.M. Rosenstein, S. Fahn, Double-blind control trial of human embryonic dopamine cell transplants in advanced Parkinson's disease, Am. Soc. Neural Transplantation and Repair, Abstract (1999) 2-1.
9. M.M.J. Giacobini, I. Stromberg, S. Almstrom, Y. Cao, L. Olson, Fibroblast growth factors enhance dopamine fiber formation from nigral grafts, Develop. Brain Res. 75 (1993) 65-73.
10. C. Rosenblad, A. Martinez-Serrano, A. Bjorklund, Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts, Neuroscience 75 (1996) 979-985.
11. H.W.M. Steinbusch, R.J. Vermeulen, J.A.D.M. Tonnaer, Basic fibroblast growth factor enhances survival and sprouting of fetal dopaminergic cells implanted in the denervated rat striatum, Prog. Brain Res. 82 (1990) 81-86.
12. I. Stromberg, L. Bjorklund, M. Johansson, A. Tomac, F. Collins, L. Olson, B. Hoffer, C. Humpel, Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo, Exper. Neurol. 124 (1993) 401-412.
13. H. Takayama, J. Ray, H.K. Raymon, A. Baird, J. Hogg, L.J. Fisher, F.H. Gage, Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease, Nat. Med. 1 (1995) 53-58.
14. Y. Wang, L.T. Tien, P.A. Lapchak, B.J. Hoffer, GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats, Cell Tiss. Res. 286 (1996) 225-233.
15. D.M. Yurek, W. Lu, S. Hipkens, S.J. Wiegand, BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons, Exp. Neurol. 137 (1996) 105-118.
16. D.M. Yurek, Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue, Exper. Neurol. 153 (1998) 195-202.
17. C.G. Causing, A. Gloster, R. Aloyz, S.X. Bamji, E. Chang, J. Fawcett, G. Kuchel, F.D. Miller, Synaptic innervation density is regulated by neuron-derived BDNF, Neuron 18 (1997) 257-267.
18. D.H. Ha, R.T. Robertson, C.E. Ribak, J.H. Weiss, Cultured basal forebrain cholinergic neurons in contact with cortical cells display synapses, enhanced morphological features, and decreased dependence on nerve growth factor, J. Comp. Neurol. 373 (1996) 451-465.
19. A. Tomac, J. Widenfalk, L.F. Lin, T. Kohno, T. Ebendal, B.J. Hoffer, L. Olson, Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult, Proc. Natl. Acad. Sci. USA 92 (1995) 8274-8278.
20. C.S. von Bartheld, R. Williams, F. Lefcort, D.O. Clary, L.F. Reichardt, M. Bothwell, Retrograde transport of neurotrophins from the eye to the brain in chick embryos: roles of the p75NTR and trkB receptors, J. Neurosci. 16 (1996) 2995-3008.
21. J.F. Dong, A. Detta, M.H. Bakker, E.R. Hitchcock, Direct interaction with target-derived glia enhances survival but not differentiation of human fetal mesencephalic dopaminergic neurons, Neuroscience 56 (1993) 53-60.
22. A. Prochiantz, U. Di Porzio, A. Kato, B. Berger, J. Glowinski, In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in the presence of their striatal target cells, Proc. Natl. Acad. Sci USA 76 (1979) 5387-5391.
23. M.C. Daguet, U. Di Porzio, A. Prochiantz, A. Kato, J. Glowinski, Release of dopamine from dissociated mesencephalic dopaminergic neurons in primary cultures in absence or presence of striatal target cells, Brain Res. 191 (1980) 564-568.
24. L.M. Hemmendinger, B.B. Garber, P.C. Hoffman, A. Heller, Target neuron-specific process formation by embryonic mesencephalic dopamine neurons in vitro, Proc. Natl. Acad Sci. USA 78 (1981) 1264-1268.
25. P.C. Hoffman, L.M. Hemmendinger, C. Kotake, A. Heller, Enhanced dopamine cell survival in reaggregates containing telencephalic targets, Brain Res. 274 (1983) 275-281.
26. Y. Tomozawa, S.H. Appel, Soluble striatal extracts enhance development of mesencephalic dopaminergic neurons in vitro, Brain Res. 399 (1986) 111-124.
27. R. Dal Toso, O. Giorgi, C. Soranzo, G. Kirschner, G. Ferrari, M. Favaron, D. Benvegnu, D. Presti, S. Vicini, G. Toffano, G.F. Azzone, A. Leon, Development and survival of neurons in dissociated fetal mesencephalic serum-free cell cultures: I. Effects of cell density and of an adult mammalian striatal-derived neuronotrophic factor (SDNF), J. Neurosci. 8 (1988) 733-745.
28. T. Takeshima, J.M. Johnston, J.W. Commissiong, Oligodendrocyte-type-2 astrocyte (O-2A) progenitors increase the survival of rat mesencephalic dopaminergic neurons from death induced by serum deprivation, Neurosci. Lett. 166 (1994) 178-182.
29. J.N. Wilcox, R. Derynck, Localization of cells synthesizing transforming growth factor-alpha mRNA in the mouse brain, J. Neurosci. 8 (1988) 1901-1904.
30. D.G. Schaar, B.A. Sieber, C.F. Dreyfus, I.B. Black, Regional and cell-specific expression of GDNF in rat brain, Exp. Neurol. 124 (1993) 368-371.
31. K.B. Seroogy, K.H. Lundgren, D.C. Lee, K.M. Guthrie, C.M. Gall, Cellular localization of transforming growth factor-alpha mRNA in rat forebrain, J. Neurochem. 60 (1993) 1777-1781.
32. I. Stromberg, L. Bjorklund, M. Johansson, A. Tomac, F. Collins, L. Olson, B. Hoffer, C. Humpel, Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo, Exp. Neurol. 124 (1993) 401-412.
33. D.L. Choi-Lundberg, M.C. Bohn, Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat, Dev. Brain Res. 85 (1995) 80-88.
34. C.A. Nosrat, A. Tomac, E. Lindqvist, S. Lindskog, C. Humpel, I. Stromberg, T. Ebendal, B.J. Hoffer, L. Olson, Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous system, Cell Tissue Res. 286 (1996) 191-207.
35. H.I. Kornblum, R.J. Hussain, J.M. Bronstein, C.M. Gall, D.C. Lee, K.B. Seroogy, Prenatal ontogeny of the epidermal growth factor receptor and its ligand, transforming growth factor alpha, in the rat brain, J. Comp. Neurol. 380 (1997) 243-261.
36. J. Widenfalk, C. Nosrat, A. Tomac, H. Westphal, B. Hoffer, L. Olson, Neurturin and glial cell line-derived neurotrophic factor receptor-beta (GDNFR-beta), novel proteins related to GDNF and GDNF-alpha with specific cellular patterns of expression suggesting roles in the developing and adult nervous system and in peripheral organs, J. Neurosci. 17 (1997) 8506-8519.
37. P.A. Kaseloo, A. Lis, H. Asada, T.A. Barone, R.J. Plunkett, In vitro assessment of neurotrophic activity from the striatum of aging rats, Neurosci. Lett. 218 (1996) 157-160.
38. P.M. Carvey, L.R. Ptak, L.C. Kao, H.L. Klawans, Striatal homogenates from animals chronically treated with haloperidol stimulate dopamine and GABA uptake in cultures of rostral mesencephalic tegmentum, Clin. Neuropharmacol. 12 (1989) 425-434.
39. P.M. Carvey, L.R. Ptak, D.H. Lin, E.S. Lo, C.M. Buhrfiend, G.E. Drucker, J.Z. Fields, Alterations in striatal neurotrophic activity induced by dopaminergic drugs, Pharm. Biochem. Behav. 46 (1993) 195-204.
40. K. Niijima, M. Araki, M. Ogawa, I. Nagatsu, F. Sato, H. Kimura, M. Yoshida, Enhanced survival of cultured dopamine neurons by treatment with soluble extracts from chemically deafferented striatum of adult rat brain, Brain Res. 528 (1990) 151-154.
41. S.J. Yu, E.S. Lo, E.J. Cochran, D.H. Lin, C.J. Faselis, H.L. Klawans, P.M. Carvey, Cerebrospinal fluid from patients with Parkinson's disease alters the survival of dopamine neurons in mesencephalic culture, Exp. Neurol. 126 (1994) 15-24.
42. Z.D. Ling, T.J. Collier, C.E. Sortwell, B.F. Daley, J.W. Lipton, T.Q. Vu, H.C. Robie, P.M. Carvey, Striatal-derived neurotrophic activity is reduced in the aged rat brain, Soc. Neurosci. Abstr. 24 (Part 2) (1998) 1947.
43. P.M. Carvey, Z.D. Ling, The case for neuroprotection with dopamine agonists, Clin. Neuropharmacol. 20 (si) (1997) S8-S21.
44. J.A. Joseph, R.E. Berger, B.T. Engel, G.S. Roth, Age-related changes in the nigrostriatum: a behavioral and biochemical analysis, J. Gerontol. 33 (1978) 643-649.
45. J.A. Joseph, C.R. Filburn, G.S. Roth, Development of dopamine receptor denervation supersensitivity in the neostriatum of the senescent rat, Life Sci. 29 (1981) 575-584.
46. F. Ponzio, G. Calderini, G. Lomuscio, G. Vantini, G. Toffano, S. Algeri, Changes in monoamines and their metabolite levels in some brain regions of aged rats, Neurobiol. Aging 3 (1982) 23-29.
47. R. Strong, T. Samorajski, Z. Gottesfeld, Regional mapping of neostriatal neurotransmitter systems as a function of aging, J. Neurochem. 39 (1982) 831-836.
48. D.G. Morgan, C.E. Finch, Dopaminergic changes in the basal ganglia. A generalized phenomenon of aging in mammals, Ann. N.Y. Acad. Sci. 515 (1988) 145-160.
49. M.A. Hebert, G.A. Gerhardt, Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in fischer 344 rats, Brain Res. 797 (1998) 42-54.
50. D.M. Yurek, S.B. Hipkens, M.A. Hebert, D.M. Gash, G.A. Gerhardt, Age-related decline in striatal dopamine release and motoric function in brown Norway/Fischer 344 hybrid rats, Brain Res. 791 (1998) 246-256.
51. C.A. Crawford, M.S. Levine, Dopaminergic function in the neostriatum and nucleus accumbens of young and aged Fischer 344 rats, Neurobiol. Aging 18 (1997) 57-66.
52. I.D. Hirschhorn, M.H. Makman, N.S. Sharpless, Dopamine receptor sensitivity following nigrostriatal lesion in the aged rat, Brain Res. 234 (1982) 357-368.
53. M. Memo, L. Lurchi, P.F. Spano, M. Trabucchi, Aging process affects a single class of dopamine receptors, Brain Res. 202 (1980) 488-492.
54. C.H. Misra, H. Shelat, R.C. Smith, Influence of age on the effects of chronic fluphenazine on receptor binding in rat brain, Eur. J. Pharmacol. 76 (1981) 317-324.
55. A. Valerio, M. Belloni, M.L. Gorno, C. Tinti, M. Memo, P. Spano, Dopamine D2, D3, and D4 receptor mRNA levels in rat brain and pituitary during aging, Neurobiol. Aging 15 (1994) 713-719.
56. N.D. Volkow, G.J. Wang, J.S. Fowler, Y.S. Ding, R.C. Gur, J. Gatley, J. Logan, P.J. Moberg, R. Hitzemann, G. Smith, N. Pappas, Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging, Ann. Neurol. 44 (1998) 143-147.
57. M.N. Friedemann, G.A. Gerhardt, Regional effects of aging on dopaminergic function in the Fischer-344 rat, Neurobiol. Aging 13 (1992) 325-332.
58. H. Kametani, S. lijima, E.L. Spangler, D.K. Ingram, J.A. Joseph, In vivo assessment of striatal dopamine release in the aged male Fisher 344 rat, Neurobiol. Aging 16 (1995) 639-646.
59. G.M. Rose, G.A. Gerhardt, G.L. Conboy, B.J. Hoffer, Age-related alteration in monoamine release from rat striatum: An in vivo electrochemical study, Neurobiol. Aging 7 (1986) 77-82.
60. E. Bezard, C.E. Gross, Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach, Prog. Neurobiol. 55 (1998) 93-116.
61. M.J. Zigmond, E.D. Abercrombie, T.W. Berger, A.A. Grace, E.M. Stricker, Compensations after lesions of central dopaminergic neurons: some clinical and basic implications, Trends Neurosci. 13 (1990) 290-296.
62. B. Fass, L.L. Butcher, Evidence for crossed projections of nigrostriatal pathway in rats, Neurosci. Lett. 22 (1981) 109-113.
63. S. Morgan, H. Steiner, C. Rosenkranz, J.P. Huston, Dissociation of crossed and uncrossed nigrostriatal projection with respect to site of origin in the rat, Neurosci. 17 (1986) 609-614.
64. T. E Robinson, I.Q. Whishaw, Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: A microdialysis study in freely moving rats, Brain Res. 450 (1988) 209-224.
65. T. Zetterstrom, M. Herrera-Marschitz, U. Ungerstedt, Simultaneous measurement of dopamine release and rotational behavior in 6-hydroxydopamine denervated rats using intracerebral dialysis, Brain Res. 376 (1986) 1-7.
66. W.Q. Zhang, H.A. Tilson, K.P. Nanry, P.M. Hudson, J.S. Hong, M.K. Stachowiak, Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage, Brain Res. 461 (1988) 335-342.